Skip to content

The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology

Field, Andrew S., Fernando Schmitt
Barcode 9783030268855
Paperback

Original price £48.54 - Original price £48.54
Original price
£48.54
£48.54 - £48.54
Current price £48.54

Click here to join our rewards scheme and earn points on this purchase!

Availability:
Low Stock
FREE shipping

Release Date: 19/08/2021

Edition: 1st ed. 2020
Label: Springer Nature Switzerland AG
Contributors: Wendy A. Raymond (Edited by), Fernando Schmitt (Edited by), Andrew S. Field (Edited by)
Language: English
Publisher: Springer Nature Switzerland AG

This text describes a system of reporting breast fine needle aspiration biopsy that uses five clearly defined categories, each described by a specific term and each with a specific risk of malignancy. The five categories are insufficient/inadequate, benign, atypical, suspicious of malignancy and malignant. Each category has a risk of malignancy and is linked to management recommendations, which include several options because it is recognized that diagnostic infrastructure, such as the availability of core needle biopsy and ultrasound guidance, vary between developed and low and middle income countries. This text includes key diagnostic cytological criteria for each of the many lesions and tumors found in the breast. The cytopathology of specific lesions is illustrated with high quality photomicrographs with clear figure descriptions. Chapters also discuss current and potential future ancillary tests, liquid based cytology, nipple cytology and management. An additional chapter provides an overview of an approach to the diagnosis of direct smears of breast fine needle aspiration biopsies.
The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology provides a clear logical approach to the diagnosis and categorization of breast lesions by FNAB cytology, and aims to facilitate communication with breast clinicians, further research into breast cytopathology and related molecular pathology, and improve patient care.